ZHEJIANG PALO ALTO PHARMACEUTICALS INC has a total of 26 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are NOVINTUM BIOTECHNOLOGY GMBH, RISEN SUZHOU PHARMA TECH CO LTD and INST OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR V V I.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | China | 4 | |
#5 | Taiwan | 3 | |
#6 | Republic of Korea | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Special acyclic compounds | |
#5 | Organic chemistry methods | |
#6 | Heterocyclic compounds | |
#7 | Microorganisms | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Xu Huaqiang | 24 |
#2 | Xi Zhijian | 24 |
#3 | Lu Chunping | 23 |
#4 | Wu Zhongshan | 20 |
#5 | Sun Feng | 8 |
#6 | Xi Zhi-Jian | 2 |
#7 | Lu Chun-Ping | 2 |
#8 | Wu Zhong-Shan | 2 |
#9 | Xu Hua-Qiang | 2 |
#10 | Wang Gaihong | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020048494A1 | Long-acting recombinant glp1-fc-cd47 protein, preparation method and use thereof | |
US2019125771A1 | Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereof | |
EP3730504A1 | Cytarabine prodrug nucleoside cyclic phosphate compound based on liver-specific delivery and use | |
TW201927309A | Liver delivery of gemcitabine prodrug nucleoside cyclic phosphate compound and application | |
EP3613753A1 | Liver-specific delivery-based anti-hepatitis c precursor drug nucleoside cyclophosphate compound and use | |
CN109956975A | Liver delivers Entecavir pro-drug nucleosides cyclic phosphate compound and application | |
WO2017219808A1 | Hepatitis c virus inhibitor and application |